WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
1. (WO2002000840) HUMAN LYASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/000840    International Application No.:    PCT/US2001/019166
Publication Date: 03.01.2002 International Filing Date: 13.06.2001
C12N 9/88 (2006.01)
Applicants: INCYTE GENOMICS, INC. [US/US]; 3160 Porter Drive Palo Alto, CA 94304 (US) (For All Designated States Except US).
THORNTON, Michael [US/US]; (US) (For US Only).
RAMKUMAR, Jayalaxmi [IN/US]; (US) (For US Only).
TRIBOULEY, Catherine, M. [FR/US]; (US) (For US Only).
YUE, Henry [US/US]; (US) (For US Only).
NGUYEN, Danniel, B. [US/US]; (US) (For US Only).
YAO, Monique, G. [US/US]; (US) (For US Only).
PATTERSON, Chandra [US/US]; (US) (For US Only).
GANDHI, Ameena, R. [US/US]; (US) (For US Only).
BURFORD, Neil [GB/US]; (US) (For US Only).
THANGAVELU, Kavitha [IN/US]; (US) (For US Only).
BAUGHN, Mariah, R. [US/US]; (US) (For US Only)
Inventors: THORNTON, Michael; (US).
RAMKUMAR, Jayalaxmi; (US).
TRIBOULEY, Catherine, M.; (US).
YUE, Henry; (US).
NGUYEN, Danniel, B.; (US).
YAO, Monique, G.; (US).
PATTERSON, Chandra; (US).
GANDHI, Ameena, R.; (US).
BURFORD, Neil; (US).
THANGAVELU, Kavitha; (US).
BAUGHN, Mariah, R.; (US)
Agent: HAMLET-COX, Diana; Incyte Genomics, Inc. 3160 Porter Drive Palo Alto, CA 94304 (US)
Priority Data:
60/213,383 23.06.2000 US
60/215,544 30.06.2000 US
60/222,818 04.08.2000 US
Abstract: front page image
(EN)The invention provides human lyases (HLYA) and polynucleotides which identify and encode HLYA. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HLYA.
(FR)La présente invention concerne des lyases humaines (HLYA) et des polynucléotides qui identifient et codent HLYA. Par ailleurs, cette invention concerne des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. De plus, cette invention concerne des méthodes diagnostiques, thérapeutiques ou prophylactiques de troubles associés à l'expression aberrante de HLYA.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)